Skip to content
10-K

Annual Report

GreenLight Biosciences Holdings, PBC

0000950170-23-010351

← back to feed
Filed
Mar 28, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 15, 2023 151.68M sh
Shares Diluted FY 2022 · Dec 31, 2022 131.98M sh
Shares Diluted FY 2022 · Dec 31, 2021 96.37M sh
Capex FY 2022 · Dec 31, 2022 $26.55M
Capex FY 2022 · Dec 31, 2021 $15.15M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$136.73M
Operating Cash Flow restated FY 2022 · Dec 31, 2021 −$91.83M
Cash And Equivalents FY 2022 · Dec 31, 2022 $68.1M
Cash And Equivalents restated FY 2022 · Dec 31, 2021 $31.45M
Stockholders Equity FY 2022 · Dec 31, 2022 $48.06M
Stockholders Equity restated FY 2022 · Dec 31, 2021 −$29.98M
Stockholders Equity restated FY 2022 · Dec 31, 2020 $79.97M
Current Liabilities FY 2022 · Dec 31, 2022 $35.56M
Current Liabilities restated FY 2022 · Dec 31, 2021 $62.34M
Total Liabilities FY 2022 · Dec 31, 2022 $100.54M
Total Liabilities restated FY 2022 · Dec 31, 2021 $93.03M
Current Assets FY 2022 · Dec 31, 2022 $71.31M
Current Assets restated FY 2022 · Dec 31, 2021 $33.78M
Total Assets FY 2022 · Dec 31, 2022 $148.6M
Total Assets restated FY 2022 · Dec 31, 2021 $63.06M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.27
Eps Diluted FY 2022 · Dec 31, 2021 −$1.17
Eps Basic FY 2022 · Dec 31, 2022 −$1.27
Eps Basic FY 2022 · Dec 31, 2021 −$1.17
Sga Expense FY 2022 · Dec 31, 2022 $35.93M
Sga Expense restated FY 2022 · Dec 31, 2021 $20.32M
Net Income FY 2022 · Dec 31, 2022 −$167.06M
Net Income restated FY 2022 · Dec 31, 2021 −$112.31M
Operating Income FY 2022 · Dec 31, 2022 −$163.92M
Operating Income restated FY 2022 · Dec 31, 2021 −$108.56M
Revenue FY 2022 · Dec 31, 2022 $6.78M
Revenue FY 2022 · Dec 31, 2021 $1.6M
Stock Repurchased FY 2022 · Aug 9, 2021 $194.9M